2018 Gastrointestinal Cancers Symposium ASCO: Social Media Monitoring Report

2018 Gastrointestinal Cancers Symposium ASCO: Social Media Monitoring Report
Product Code: Conference Listening
Availability: In Stock
Price: $2,999.00
Ex Tax: $2,999.00
Qty:  

Social media monitoring of Gastrointestinal Cancers Symposium is done to understand:

  • Major Theme of Discussion
  • Key Influencer
  • Key Engaging Topics
  • HCPs and Patients/others response towards the manufacturers 
  • Benchmarking of digital asset utilization by manufacturer

    Scope to Improve 

    Tracking and analysing people perceptions and sentiments 

    Tracking any theme in greater details

    KOL and digital asset benchmarking in greater details 


    GI Symposium Day 1Bristol Meyer to be found as active manufacturer on social media channels during GI SymposiumHCP discussion around Esophageal and Gastric cancerHCP discussion around Colorectal Cancer during Gastrointestinal Cancer SymposiumHCP discussion around clinical trialsPost discussion around clinical trial in GI SymposiumTop 5 key opinion leaders by TweetsTop 5 key opinion leaders by EngagementGI Symposium Day 2Bristol Meyer and other found as the active manufacturer on social media during GI SymposiumBristol Mayer and other are mentioned majority of times on social media channels during GI SymposiumHCP raised questions on Diagnostic and treatment optionsHCP discussion around Colorectal cancer clinical trial during GI SymposiumPost discussion around clinical trial on social media channels by health care practitionerDisease which are highly discussed during GI SymposiumPost discussion around clinical trial in GI SymposiumAnother Top 5 key opinion leaders by TweetsAnother Top 5 key opinion leaders by EngagementGI Symposium Day 3Bristol Meyer are found as digitally active manufacturer on social media during GI SymposiumBristol Mayer and other are mentioned majority of times on social media channels during GI Symposium followed by Ipsen and MerckHCP are found to be positive around clinical outcomes for colon cancer during GI SymposiumHCP seems to be positive around Immunotherapy treatment options for colorectal pateintsPost discussion around Gastric cancer and Hepatocellular CarcinomaPost discussion around Clinical trial in GI Cancer SymposiumThird day Top 5 key opinion leaders by TweetsThird day Top 5 key opinion leaders by Engagement

Socioinsider © 2018